REGENXBIO
Sarah Thomas is a seasoned executive in quality assurance and compliance with extensive experience in the pharmaceuticals and biotechnology sectors. Currently serving as Senior Vice President of Quality at REGENXBIO Inc. since November 2016, Sarah has previously held significant roles including Vice President of Quality at GSK and Vice President of Quality at Human Genome Sciences. Early career positions include Director of Quality Assurance at Cell Genesys and Manager of Quality Assurance at both ALZA Corporation and Sequus Pharmaceuticals. Sarah holds an MBA from The George Washington University School of Business, a certificate in Project Management from the University of California, Berkeley, and a B.S. in Chemistry from Butler University.
This person is not in any teams
REGENXBIO
4 followers
REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.